pillbase.ru

PNV-Omega

Active substance: ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, BIOTIN, CALCIUM CARBONATE, FERROUS FUMARATE, POTASSIUM IODIDE, MAGNESIUM OXIDE, DOCONEXENT, ICOSAPENT

CAPSULE, GELATIN COATED · ASCORBIC ACID 85 mg/1, CHOLECALCIFEROL 200 [iU]/1, .ALPHA.-TOCOPHEROL 10 [iU]/1, PYRIDOXINE HYDROCHLORIDE 25 mg/1, FOLIC ACID 1 mg/1, CYANOCOBALAMIN 12 ug/1, BIOTIN 250 ug/1, CALCIUM CARBONATE 140 mg/1, FERROUS FUMARATE 28 mg/1, POTASSIUM IODIDE 150 ug/1, MAGNESIUM OXIDE 45 mg/1, DOCONEXENT 300 mg/1, ICOSAPENT 40 mg/1

United StatesActive

Marketing holder: Acella Pharmaceuticals, LLC

Verified 2026-10-09 · openFDA NDC

Composition
Registration
Registration number
42192-332
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 42192-332 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 42192-332 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 42192-332 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 42192-332 · Verified 2026-10-09 · open in source
  • ingredients.2 · openFDA NDC · 42192-332 · Verified 2026-10-09 · open in source
  • ingredients.3 · openFDA NDC · 42192-332 · Verified 2026-10-09 · open in source
  • ingredients.4 · openFDA NDC · 42192-332 · Verified 2026-10-09 · open in source
  • ingredients.5 · openFDA NDC · 42192-332 · Verified 2026-10-09 · open in source
  • ingredients.6 · openFDA NDC · 42192-332 · Verified 2026-10-09 · open in source
  • ingredients.7 · openFDA NDC · 42192-332 · Verified 2026-10-09 · open in source
  • ingredients.8 · openFDA NDC · 42192-332 · Verified 2026-10-09 · open in source
  • ingredients.9 · openFDA NDC · 42192-332 · Verified 2026-10-09 · open in source
  • ingredients.10 · openFDA NDC · 42192-332 · Verified 2026-10-09 · open in source
  • ingredients.11 · openFDA NDC · 42192-332 · Verified 2026-10-09 · open in source
  • ingredients.12 · openFDA NDC · 42192-332 · Verified 2026-10-09 · open in source